Moreover, recent studies indicating the place of COX-2 inhibitors in cancer chemotherapy and neurological diseases such as Parkinson and Alzheimer’s diseases still continues to attract investigations on the development of COX-2 inhibitors. Here, PTGS2 is linked to nervous system disorder.